To buy CJC-1295 (No DAC) in New York, PX1 Research provides premium lyophilized vials with same-day dispatch from our California and Arizona hubs (Monday–Friday before 12 PM PST). Every lot features USA-synthesized peptides independently verified by HPLC and mass spectrometry, lot-specific endotoxin testing, and fast 2–3 day domestic shipping directly to New York laboratories without customs exposure.
To buy CJC-1295 (No DAC) in New York, PX1 Research provides premium lyophilized vials with same-day dispatch from our California and Arizona hubs (Monday–Friday before 12 PM PST). Every lot features USA-synthesized peptides independently verified by HPLC and mass spectrometry, lot-specific endotoxin testing, and fast 2–3 day domestic shipping directly to New York laboratories without customs exposure.
Securing high-purity CJC-1295 (No DAC) for preclinical research in the New York metropolitan area requires a reliable domestic supply chain. PX1 Research fulfills orders directly from facilities in California and Arizona, ensuring fast domestic shipping to laboratories across New York State without the customs holds or international shipping delays common with overseas vendors.
Orders placed before 12 PM PST (3 PM EST) ship the same business day, arriving at New York institutions in 2 to 3 business days. Every shipment includes lot-specific third-party analytical documentation—including High-Performance Liquid Chromatography (HPLC), Electrospray Ionization Mass Spectrometry (ESI-MS), and bacterial endotoxin testing—guaranteeing verified purity above 98% for consistent in vitro and animal model trials.
The New York metropolitan region hosts one of the dense research ecosystems in the world, spanning academic medical centers, biotechnology incubators, and private research laboratories in Manhattan, Brooklyn, Long Island, and the Hudson Valley. Researchers operating in these fast-paced environments require minimal turnaround times and strict analytical integrity when acquiring active pharmaceutical ingredients and research peptides.
Relying on overseas peptide vendors poses significant hazards to experimental schedules. International shipments frequently suffer from US Customs and Border Protection (CBP) holds, FDA import alerts, and untracked transit periods lasting weeks. Furthermore, international packages are vulnerable to ambient temperature fluctuations during extended customs clearance, compromising peptide integrity before arrival. By sourcing directly from a domestic USA supplier like PX1 Research, New York laboratories eliminate customs risks, secure predictable 2–3 day transit, and maintain full supply chain transparency.
CJC-1295 (No DAC), also known as Modified GRF 1-29, is a synthetic 29-amino-acid peptide analog of Growth Hormone-Releasing Hormone (GHRH). It represents the core active sequence of endogenous GHRH (1-29) with four specific amino acid substitutions (D-Ala2, Gln8, Ala15, and Leu27) designed to enhance enzymatic stability against dipeptidyl peptidase IV (DPP-IV) degradation without altering its receptor binding kinetics.
In preclinical literature, CJC-1295 (No DAC) is studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream IGF-1 levels for tissue repair research. Unlike native GHRH, which exhibits a plasma half-life of mere minutes, the modified 29-amino-acid chain demonstrates an extended biological half-life while retaining a physiological, pulsatile pattern of GH secretion. When researchers prepare to order 10 mg vials of Retatrutide or CJC-1295 (No DAC), evaluating these pharmacokinetic properties is essential for designing accurate assay parameters.
A critical distinction in GHRH research is the structural difference between CJC-1295 (No DAC) and CJC-1295 with DAC (Drug Affinity Complex). The Drug Affinity Complex involves a lysine residue conjugated to a maleimidopropionic acid (MPA) group at the C-terminus. This group enables covalent binding to circulating serum albumin, extending the peptide's elimination half-life to several days and producing continuous elevation of baseline growth hormone levels.
Conversely, CJC-1295 (No DAC) lacks this conjugate group. As a result, its half-life in animal models is measured in minutes to hours rather than days. This physiological half-life allows researchers to induce acute, controlled GH pulses without inducing tonic GH receptor down-regulation or persistent IGF-1 elevation. For assays focused on discrete physiological signaling pulses, Modified GRF 1-29 is the preferred compound. Researchers investigating GHRH kinetics can review detailed structural data on our dedicated CJC-1295 (No DAC) research page.
In cellular and preclinical animal models, researchers frequently explore the synergistic activation of the growth hormone secretagogue receptor (GHSR-1a) and the GHRH receptor. Co-administering a GHRH analog such as CJC-1295 (No DAC) alongside a Growth Hormone Secretagogue (GHS) like Ipamorelin yields a release of growth hormone significantly greater than the additive sum of either peptide administered independently.
While CJC-1295 (No DAC) stimulates cAMP accumulation via the GHRH pathway, ghrelin receptor agonists activate the phospholipase C pathway. Laboratories studying cell proliferation, connective tissue matrix protein expression, or metabolic regulation often evaluate dual-peptide models. To explore related secretagogues for comparative studies, browse our complete research peptide catalog or view specifications for Ipamorelin research vials.
Shipping research peptides to New York requires addressing regional seasonal conditions. New York experiences severe winter temperatures that can subvert uninsulated peptide shipments to below freezing, as well as high summer heat and humidity in urban corridors during July and August. Temperature extremes during transit can induce physical degradation or moisture introduction in improperly sealed containers.
PX1 Research mitigates climate exposure through climate-conscious packaging. All peptides are supplied in vacuum-sealed glass vials featuring protective flip-off seals and internal rubber stoppers designed to prevent moisture ingress. Lyophilized peptides remain stable at room temperature during typical 2–3 day domestic transit from our West Coast facilities to New York destinations. Upon receipt in your New York lab, lyophilized products should immediately be transferred to storage at -20°C for long-term stability.
Assessing vendor quality is a mandatory step for laboratory procurement officers and principal investigators. Unverified peptides introduce unaccounted variables that invalidate experimental outcomes and waste institutional resources. When evaluating suppliers to buy CJC-1295 (No DAC) in New York, ensure the vendor complies with these strict analytical standards:
1. Batch-Specific High-Performance Liquid Chromatography (HPLC): Ensure the vendor provides a full raw HPLC chromatogram showing retention time, peak integration, and quantified purity exceeding 98%. Refuse suppliers offering simple summary sheets or static sample certificates.
2. Mass Spectrometry (MS) Identity Verification: Demand Electrospray Ionization (ESI) or MALDI-TOF mass spec reports confirming the exact molecular weight of the peptide chain against its theoretical mass (3357.9 g/mol for CJC-1295 No DAC).
3. Quantitative Endotoxin Testing: Confirm that bacterial endotoxins (LPS) are quantified using Limulus Amebocyte Lysate (LAL) assays, with levels documented below 0.01 EU/mg to avoid inflammatory interference in cell cultures.
4. Domestic Synthesis and Fulfillment: Verify that fulfillment originates within the United States to prevent border confiscation, customs clearance holds, and extended shipping windows.
5. Direct Lot Traceability: Require individual lot numbers printed directly on each vial label that correspond identically to the downloadable third-party Certificate of Analysis.
The online research chemical market contains numerous entities operating without sufficient quality controls. Recognizing warning signs protects your research budget and ensures sample reliability.
Be alert to suppliers that display generic COAs with blurred dates, missing batch numbers, or altered lab logos. Avoid vendors making explicit human consumption or medical usage claims; legitimate peptide suppliers enforce strict 'for laboratory research use only' compliance. Finally, avoid vendors that operate drop-shipping models from foreign warehouses, as this introduces severe delays and leaves shipments vulnerable to federal border inspections.
Evaluating supplier capabilities across critical technical dimensions highlights the contrast between domestic verification and unverified importing:
- Purity Verification: PX1 Research provides batch-specific RP-HPLC showing >98% purity. Overseas resellers often provide non-batch-specific COAs or unverified claims.
- Identity Mass Testing: PX1 Research provides ESI-MS molecular weight matching theoretical mass per lot. Resellers often lack mass spec documentation entirely.
- Endotoxin Controls: PX1 Research conducts LAL endotoxin testing on every lot (<0.01 EU/mg). Overseas resellers rarely perform endotoxin assays.
- Fulfillment Origin: PX1 Research dispatches directly from California and Arizona. Resellers drop-ship from overseas or use unmonitored residential re-mailers.
- Shipping Speed to New York: PX1 Research delivers in 2–3 business days via tracked domestic carrier. Resellers require 14–30 business days with high customs seizure risk.
- Technical Support: PX1 Research provides responsive US-based support with direct access to batch documentation. Resellers offer limited or non-responsive buyer contact.
Proper reconstitutive handling is essential to maintain biological activity during in vitro and animal model protocols. CJC-1295 (No DAC) is supplied as a lyophilized (freeze-dried) powder under vacuum seal.
Reconstitute the sample using sterile Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Normal Saline, allowing the solvent to run slowly down the interior glass wall rather than force-injecting directly onto the lyophilized cake. Gently swirl the vial until dissolved; avoid vigorous shaking, which can cause shearing of the peptide backbone.
Prior to reconstitution, store lyophilized vials in a dry freezer at -20°C. Once reconstituted, store the liquid solution at 2°C to 8°C and use within 30 days. Minimize freeze-thaw cycles to prevent structural degradation over extended research timelines. Additional handling literature can be accessed in our peptide research library.
PX1 Research streamlines procurement for researchers and purchasing managers in New York, NY. Our direct online platform eliminates middleman markups and guarantees rapid dispatch to academic, clinical, and industrial laboratories across the region.
Orders are packaged in secure, temperature-resilient, tamper-evident containers containing glass vials sealed under sterile conditions. Orders placed Monday through Friday prior to 12 PM PST (3 PM EST) ship same-day via expedited domestic carriers (USPS Priority, FedEx, or UPS), providing direct end-to-end tracking to your New York laboratory facility.
Every vial is labeled with a distinct lot number matching its analytical COA, which is downloadable directly from our portal prior to or upon delivery. For high-volume projects, bulk inquiries, or institution-wide procurement, visit our wholesale portal or proceed to order directly through our CJC-1295 (No DAC) product page to secure your research inventory today.
Is CJC-1295 (No DAC) legal to buy in New York for research?
Yes. CJC-1295 (No DAC) is legal to purchase in New York for laboratory research use, in vitro testing, and preclinical animal trials. It is not an FDA-approved drug or controlled substance, but it must be purchased strictly for scientific research purposes and not for human or veterinary administration.
How fast does PX1 Research ship CJC-1295 (No DAC) to New York, NY?
Orders placed before 12 PM PST (3 PM EST) Monday through Friday dispatch same-day from our California or Arizona hubs. Domestic transit to New York addresses typically takes 2 to 3 business days via standard priority carrier service.
Do you provide a COA for my lot of CJC-1295 (No DAC)?
Yes. Every single lot of CJC-1295 (No DAC) is paired with a lot-specific Certificate of Analysis generated by an independent third-party laboratory. The COA includes full RP-HPLC chromatograms, ESI-MS mass spectrometry verification, and quantitative LAL endotoxin testing results.
What purity is guaranteed for PX1 Research CJC-1295 (No DAC)?
PX1 Research guarantees high-purity research peptides with a minimum HPLC-verified purity of 98.0%. Exact purity levels for your specific lot are listed on the accompanying Certificate of Analysis.
What is the structural difference between CJC-1295 No DAC and Modified GRF 1-29?
CJC-1295 (No DAC) and Modified GRF 1-29 refer to the exact same 29-amino-acid peptide sequence. The term 'No DAC' is utilized to clarify that the molecule lacks the Drug Affinity Complex extension, giving it a physiological half-life rather than a prolonged multi-day duration.
How does seasonal weather in New York affect peptide shipping?
Lyophilized (freeze-dried) peptides are stable at ambient room temperatures during short-term domestic transit. PX1 Research utilizes vacuum-sealed glass vials and climate-conscious outer packaging to shield peptides from ambient heat or freezing temperatures during 2–3 day transit to New York.
How should CJC-1295 (No DAC) be stored upon arrival at our New York lab?
Upon arrival, store unopened lyophilized vials in a standard freezer at -20°C for long-term stability (up to 24 months). Once reconstituted with bacteriostatic water, store the liquid solution in a laboratory refrigerator at 2°C to 8°C and use within 30 days.
Can I order CJC-1295 (No DAC) in bulk for institution-wide research in NY?
Yes. PX1 Research supports academic institutions, biotechnology companies, and contract research organizations with bulk unit volumes. Institutional buyers can access custom pricing and dedicated lot reservation through our wholesale channel.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.